Skyepharma - Charts & News

This taken from Yahoo ! Message Board: SKYE stateside (USA)

by: smallpharm
Long-Term Sentiment:

STRONG BUY

I've been following drug delivery companies for almost ten years.
ThIS IS REALLY A BUYING OPPORTUNITY.There are questions about Paxil now,
but if you've been reading the annual report,you can see that the drug pipelie
(both for pharma partner and SKYE-internal products) is growing and
progressing annually.They've got key technologies which can be applied to a
range of drugs,and they are just that,in a very consistent and successful manner.Just look at how their products(or reformulated products)move through
the clinical pipeline year to year.There is really no reason for this stock not to hit 40Dollars a share in the next few years- currently 6.84usd.

But in the interim,SKYE certainly has potential to go back up into the
10-12 usd range.So either way,it is a buying opportunity.

mike

.....................
I concur FWIW.
Ironically, the recent plunge in sp could well be the catalyst for a
full appreciation of the TRUE worth of Skyepharma !
Finance Director buying 100'000 shares at .35p ,very much from the
poop-deck as it were,very positive sign.This man is in the know and
not in the habit of throwing HIS OWN money to the wind and evidently
looking for a quick teturn!

Bright times ahead......SIT TIGHT !!